Journal
INTERNATIONAL JOURNAL OF MEDICAL ROBOTICS AND COMPUTER ASSISTED SURGERY
Volume 17, Issue 4, Pages -Publisher
WILEY
DOI: 10.1002/rcs.2269
Keywords
adrenalectomy; minimally invasive surgery; nephrectomy; prostate cancer; pyeloplasty; radical prostatectomy; robotics; Senhance(®)
Categories
Ask authors/readers for more resources
This study presented the experience in urological surgeries using the Senhance(R) robotic surgery system for upper urinary tract operations and extraperitoneal radical robotic prostatectomies. The average estimated blood loss, operating time, and length of hospital stay varied slightly between the two groups of patients, with low rates of complications.
Background The Senhance(R) robotic surgery system is a novel robotic platform used in several European and World centres. We present our experience in urologic surgery using this platform. Patients and Methods From May 2019 to December 2020, we performed 30 operations of upper urinary tract (UUT) and 70 extraperitoneal radical robotic prostatectomies (RRP). Relevant data were prospectively collected for key outcomes. Results The median age for UUT was 51, and for RRP 65 years. The average estimated blood loss for UUT was 30, and for RRP 200 ml. The average operating time for UUT was 160, and for RRP 200 min. In-hospital stay for UUT was on average 4, and for RRP 5 days. In UUT group, one patient had Clavien-Dindo complication grade II and one had IIIb. In RRP, three patients had grade I complications and three patients had grade II complications. Catheter was removed on average 8 days after RRP. Conclusion The Senhance(R) robotic system is a safe and feasible approach to urological surge.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available